載入...
TAM Receptor Tyrosine Kinases as Emerging Targets of Innate Immune Checkpoint Blockade for Cancer Therapy
Cancer immunotherapy utilizing T cell checkpoint inhibitors has shown tremendous clinical success. Yet this mode of treatment is effective in only a subset of patients. Unresponsive patients tend to have non-T cell inflamed tumors that lack markers associated with the activation of adaptive anti-tum...
Na minha lista:
| 發表在: | Immunol Rev |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5381815/ https://ncbi.nlm.nih.gov/pubmed/28258690 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/imr.12522 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|